Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CBB1007 trihydrochloride is a selective, reversible, and substrate competitive LSD1 inhibitor (IC50: 5.27 μM for hLSD1).
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 1,280 | 待询 | ||
5 mg | ¥ 1,930 | 待询 | ||
10 mg | ¥ 2,930 | 待询 | ||
50 mg | ¥ 6,960 | 待询 | ||
100 mg | ¥ 10,800 | 待询 | ||
200 mg | 待询 | 待询 | ||
500 mg | 待询 | 待询 | ||
1 mL * 10 mM (in DMSO) | ¥ 2,730 | 待询 |
产品描述 | CBB1007 trihydrochloride is a selective, reversible, and substrate competitive LSD1 inhibitor (IC50: 5.27 μM for hLSD1). |
体外活性 | CBB1007 efficiently can block LSD1-mediated demethylation of H3K4Me2 and H3K4Me (IC50 ≤ 5 μM) with no effect on H3K4Me3 and H3K9Me2, and LSD2 and JARID1A activities. Increases H3K4Me2 and H3K4Me contents (IC50 ≤ 5 μM), and causes activation of epigenetically suppressed CHRM4/M4-ArchR and SCN3A genes in F9 cells (IC50 ≤ 3.74 μM). |
别名 | CBB1007 trihydrochloride |
分子量 | N/A |
CAS No. | 2070015-03-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 54 mg/mL (83.85 mM)
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
CBB1007 trihydrochloride (1379573-92-8 free base) 2070015-03-9 Others 1379573-92-8 CBB 1007 Trihydrochloride CBB-1007 CBB1007 CBB-1007 Trihydrochloride CBB1007 trihydrochloride (1379573 92 8 free base) CBB1007 Trihydrochloride 1379573-92-8 free base CBB-1007 trihydrochloride (1379573-92-8 free base) CBB 1007 CBB1007 trihydrochloride CBB1007 trihydrochloride (1379573928 free base) Inhibitor inhibitor inhibit